Medicenna Therapeutics : to Participate in Upcoming January Investor Conferences - Form 6-K
Medicenna to Participate in Upcoming January Investor Conferences TORONTO and HOUSTON, Jan. 05, 2022 -- Medicenna Therapeutics Corp. , a clinical stage immuno-oncology... | January 5, 2022
Source: marketscreener.com